The Current Ratio as of September 2024 (TTM) for AIM ImmunoTech Inc. (AIM) is 1.17

According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.17. This represents a change of -46.87% compared to the average of 2.21 of the last 4 quarters.

AIM ImmunoTech Inc. (AIM) Historical Current Ratio (quarterly & annually)

How has AIM Current Ratio performed in the past?

The mean historical Current Ratio of AIM ImmunoTech Inc. over the last ten years is 16.18. The current 1.17 Current Ratio has changed 624.42% with respect to the historical average. Over the past ten years (40 quarters), AIM's Current Ratio was at its highest in in the December 2021 quarter at 74.61. The Current Ratio was at its lowest in in the December 2018 quarter at 0.72.

AIM ImmunoTech Inc. (AIM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AIM ImmunoTech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AIM ImmunoTech Inc. (AIM) Average Current Ratio

How has AIM Current Ratio performed in the past?

The current Current Ratio of AIM ImmunoTech Inc. (AIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AIM ImmunoTech Inc. (AIM) Current Ratio vs. Peers

How is AIM’s Current Ratio compared to its peers?

AIM ImmunoTech Inc.’s Current Ratio is less than Aptorum Group Limited (1.18), less than Applied Molecular Transport Inc. (4.99), less than Fresh Tracks Therapeutics, Inc. (6.98), greater than BioCardia, Inc. (0.39), less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), greater than Revelation Biosciences, Inc. (1.10), less than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (19.22), less than Forte Biosciences, Inc. (2.82), less than Cellectar Biosciences, Inc. (2.54), less than Diffusion Pharmaceuticals Inc. (10.96), greater than Tonix Pharmaceuticals Holding Corp. (1.15), less than Onconova Therapeutics, Inc. (1.93), less than Jaguar Health, Inc. (2.10), less than Vaxart, Inc. (4.54), greater than VBI Vaccines Inc. (0.34), less than Pulmatrix, Inc. (6.33), less than Capricor Therapeutics, Inc. (1.37), greater than Akari Therapeutics, Plc (0.58), less than Soleno Therapeutics, Inc. (29.24),

Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.